SS

Sam Sutton

Bridgepoint in €800m eyeglass exit

The deal for eyeglass retailer Alain Afflelou was struck just one day after Bridgepoint confirmed it had entered exclusive talks with Lion Capital.

2 min read · 08 February 2013

PSERS commits $450m to private equity, debt

Among the commitments was a $100m allocation to Trilantic Capital Partner, which has hit the market for the first time since spinning out of Lehman Brothers.

2 min read · 08 February 2013

Rice to step down as CD&R chairman

Joseph Rice, a pioneer of the buyout model who will leave the firm in June, earlier this year said at an industry conference that CD&R would likely never go public like several of its peers.

2 min read · 18 January 2013

Sankaty Advisors launches fifth fund

Bain Capital’s credit affiliate picked up a pair of commitments for Fund V last week, targeting $3.5bn for investments in the US and Europe.

2 min read · 18 January 2013

BTG Pactual raises $1.96bn in IPO

The Brazilian investment bank’s IPO was backed by JC Flowers & Company, the Ontario Teachers’ Pension Plan Board and several major sovereign wealth funds.

1 min read · 18 January 2013

HarbourVest moves into mainland China

The global fund of funds specialist has hired former JP Morgan managing director Sally Shan to expand the firm’s efforts to Beijing.

2 min read · 18 January 2013

New Mexico forces transparency concessions

Sun Mountain Capital has agreed to new transparency requirements in response to a minor controversy surrounding its investment in Growstone through the state’s co-investment programme.

2 min read · 18 January 2013

TPG launches sixth Asian fund

TPG has come back to the market with its sixth Asia vehicle, targeting $4bn. The firm allowed LPs to lower their commitments by as much as 10% on its previous Asia fund in 2009.

2 min read · 18 January 2013

Riverside adds Mercury partner

Erick Bronner has been named the head of The Riverside Company’s investor relations team after parting ways with Mercury Capital Advisors in January.

2 min read · 18 January 2013

Essex Woodlands, 3i in $650m pharma exit

The sale of EUSA Pharma to Jazz Pharmaceuticals will generate $200m in proceeds for Essex Woodlands, says managing director Dr. Petri Vainio.

2 min read · 18 January 2013

Showing 181 to 190 of 558 results
1…1820…56